Pharmaceutical Products for Cder Research Studies Tender - 137287974

Procurement Summary

Country: USA

Summary: Pharmaceutical Products for Cder Research Studies Idiq

Deadline: 18 Mar 2026

Posting Date: 07 Mar 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 137287974

Document Ref. No.: CDER-2026-132721

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

MARKET RESEARCH PURPOSES ONLY
NOT A REQUEST FOR PROPOSAL OR SOLICITATION
The U.S. Food and Drug Administration (FDA) is conducting market research to support the Center for Drug Evaluation and Research (CDER), requirement for Pharmaceutical Manufacturer/Supplier to provide brand name and/or generic pharmaceuticals to include small molecule and peptide therapeutics.
The FDA is seeking small business sources to determine the availability and capability of small businesses capable of providing the required supplies. Other than small business concerns are also encouraged to submit capability statements. The following information is provided to assist the FDA in conducting Market Research to identify potential contractors for this effort.
The associated North American Industry Classification System (NAICS) Code is- 325412 - Pharmaceutical Preparation Manufacturing; the applicable Small Business Size Standard is 1300 employees.
Statement of Work
Background:
The U.S. Food and Drug Administration (FDA) is engaged in laboratory, animal and human research to develop tools and methodologies to evaluate generic drug equivalence. The Center for Drug Evaluation and Research (CDER), requires a Pharmaceutical Manufacturer/Supplier to provide brand name and/or generic pharmaceuticals to include small molecule and peptide therapeutics, drug-device combination products, and contrast agents. FDA collaborates with external investigators in industry and academia as well as internal investigators in various FDA laboratories to conduct research that will advance public health by providing access to safe and effective generic drugs. These research studies include: investigation of the quality of drug products associated with adverse events, comparison of branded and generic products in physicochemical characterization and in vitro release testing, analysis of methods to assay drugs of a particular class and surveillance of marketplace drug quality. Often the quantity ...
Notice ID: cder-2026-132721

Department/Ind. Agency: health and human services, department of

Sub-tier: food and drug administration

Office: fda office of acq grant svcs

Product Service Code: 6505 - drugs and biologicals

NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing

Inactive Dates: apr 02, 2026

Inactive Policy: 15 days after response date

Documents

 Tender Notice

Documents.zip